New prohibited substance case under FEI Anti-Doping Rules
The FEI has announced an adverse analytical finding involving a prohibited substance under the FEI Anti-Doping Rules.
Samples taken at the CSI 4* at Coapexpan (MEX) on 14 October 2016 from the horse La Petite Fleur 6 (FEI ID 103TN40/MEX), ridden by Andres Arozarena (FEI ID 10094207/MEX) to finish as runner-up in the speed class on the second day of the event, have returned positive for Piroxicam.
Piroxicam, a non-steroidal anti-inflammatory drug used for the treatment of rheumatic disorders, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The athlete has been provisionally suspended from the date of notification (20 December 2016). The horse has also been suspended for a two-month period.
Further details on this case can be found here.
Suzanne: BA (Hons) in Marketing Management, Diploma in Equine Studies, B.E.M.A Member. An entrepreneur with over a decade of experience in marketing, publishing, content curation, editing, and media writing. Avid equestrian, riding since the age of 5 and owning horses for over 35 years. Proud mum to humans, dogs, and a horse.